Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORLUX for recurrent psychotic symptoms in major depressive disorder
NCT00128505Phase 3Completed
- Sponsor
- Corcept Therapeutics
- Start
- Aug 2005
- Primary completion
- Nov 2006
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 3 trial of mifepristone, sponsored by Corcept Therapeutics. Started Aug 2005; status: completed.
02
Drugs
mifepristone
Beyond the preview
Go deeper on NCT00128505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128505.